Human vaccinia-like virus outbreaks in São Paulo and Goiás States, Brazil: virus detection, isolation and identification

Nagasse-Sugahara, Teresa Keico; Kisielius, Jonas José; Ueda-Ito, Marli; Curti, Suely Pires; Figueiredo, Cristina Adelaide; Cruz, Aurea Silveira; Silva, Maysa Madalena J; Ramos, Carmen Helena; Silva, Maria Claudia C; Sakurai, Tiyo; Salles-Gomes, Luis Florêncio.
Rev. Inst. Med. Trop. Säo Paulo ; 46(6): 315-322, Nov.-Dec. 2004. ilus, mapas, tab, graf
Artigo em Inglês | LILACS | ID: lil-391587

Documentos relacionados

  1. Building a next-generation, two-component protein subunit vaccine against monkeypox virus.
  2. Optimization of translation enhancing element use to increase protein expression in a vaccinia virus system.
  3. Hesperetin blocks poxvirus replication with a low tendency to select for drug-resistant viral variants.
  4. Resistance Evolution against Host-directed Antiviral Agents: Buffalopox Virus Switches to Use p38-ϒ under Long-term Selective Pressure of an Inhibitor Targeting p38-α.
  5. A succession of two viral lattices drives vaccinia virus assembly.
  6. Rapid and quantitative evaluation of vaccinia virus-induced host shutoff using newly generated cell lines stably expressing secreted Gaussia luciferase.
  7. Vaccinia viral A26 protein is a fusion suppressor of mature virus and triggers membrane fusion through conformational change at low pH.
  8. Trafficking and retention of protein antigens across systems and immune cell types.
  9. Zoonotic vaccinia virus strains belonging to different genetic clades exhibit immunomodulation abilities that are proportional to their virulence.
  10. Rational design of a 'two-in-one' immunogen DAM drives potent immune response against mpox virus.